Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiovascular effects of antimuscarinic agents and beta3-adrenergic receptor agonist for the treatment of overactive bladder

Published:2018-03-20 Issue:5 Volume:17 Page:487-497
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Rosa Gian Marco¹,Baccino Danilo¹,Valbusa Alberto¹,Scala Carolina²³,Barra Fabio²³,Brunelli Claudio¹,Ferrero Simone²³

Affiliation:

1. Department of Internal Medicine, Cardiology, Ospedale Policlinico San Martino, Genoa, Italy

2. Academic Unit of Obstetrics and Gynecology, Ospedale Policlinico San Martino, Genoa, Italy

3. Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genoa, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2018.1453496

Reference94 articles.

1. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction

2. Dynamic Progression of Overactive Bladder and Urinary Incontinence Symptoms: A Systematic Review

3. Persistence and compliance with medication management in the treatment of overactive bladder

4. Systematic review of overactive bladder therapy in females

5. Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of diarrhea or constipation with urinary incontinence in adults: A cross‐sectional analysis of the National Health and Nutrition Examination Survey;Neurourology and Urodynamics;2024-05-02

2. Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia;Expert Opinion on Drug Safety;2023-12-02

3. Clinical pharmacology of β-3 adrenergic receptor agonists for cardiovascular diseases;Expert Review of Clinical Pharmacology;2023-09-20

4. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

5. The Differential Risk of Mortality Among Users of Overactive Bladder Anticholinergic Medications and β3 Agonists;European Urology Focus;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3